Analyzing exon 5 in the TP53 gene in relapsed childhood ALL revealed a mutation in 19% of patients (12% in B-lineage and 33% in T-lineage), most of them were identified in the relapse phase. This evidence concerns the gene TP53 and acute lymphoblastic leukemia.